Author

Zheng Zhang

h-index 0 View on Semantic Scholar

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Venetoclax plus azacitidine in higher-risk myelodysplastic syndromes: a treatment-purpose framework for interpreting response depth

Venetoclax plus azacitidine has demonstrated substantial clinical activity in treatment-naïve higher-risk myelodysplastic syndromes (HR-MDS), including high rates of complete remission, marrow complete remission, and overall response. However, recent phase 3 experience indicates that greater response depth does not nec...

Xin-Fu Zou, Jin-Yang Bu, Ao-Jiao Chu et al. · Frontiers in Medicine · 0 citations

Review Open access Aug 2026

Research progress on BTG2 in non-tumor diseases (Review)

This review systematically synthesizes advances in the pivotal, context-dependent roles of BTG2 in non-tumor pathologies, including fibrotic, neurological, cardiovascular, inflammatory, metabolic and other systemic diseases.

Shu-Ling Li, Xiao-Mei Liu, Zheng Zhang et al. · International Journal of Mol... · 0 citations